Giant Cell Arteritis Drugs Market to Reach US$2.62 Billion by 2035 as Oral Targeted Therapy Challenges Injectable Biologics

The global giant cell arteritis drugs market reached US$1.11 billion in 2025 and is expected to reach US$2.62 billion by 2035, growing at a CAGR of 9% during 2026-2035. The market is moving away from a treatment model dominated by